Tvardi Therapeutics to Participate in Upcoming Investor Events

Rhea-AI Summary

Tvardi Therapeutics (NASDAQ: TVRD), a clinical-stage biopharma company targeting STAT3 for inflammatory and proliferative diseases, will take part in two June 2026 investor events.

Management will join fireside chats at the Jefferies Global Healthcare Conference and the Raymond James BioPharma CEO Strategy Series, with live webcasts and 90-day replays.

News Market Reaction – TVRD

-6.75%

5 alerts

-6.75% Session close to close

+3.9% Peak Tracked

-5.8% Trough Tracked

$35.37M Market Cap

1.3x Rel. Volume

In the May 21 session, TVRD declined 6.75%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.9% during that session. Argus tracked a trough of -5.8% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events:

Jefferies Global Healthcare Conference
Format: Fireside Chat and 1-on-1 Meetings
Date: Thursday, June 4, 2026
Time: 8:10 AM ET
Location: New York, NY

Raymond James BioPharma CEO Strategy Series
Format: Fireside Chat
Date: Friday, June 5, 2026
Time: 10:00 AM ET
Registration Link: Here

The webcasts of the Jefferies and Raymond James fireside chats will be accessible on the Tvardi Investors’ website. A replay of the webcasts will be available for approximately 90 days following the conference.

About Tvardi Therapeutics

Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need. STAT3 is a central mediator across critical signaling pathways that drive uncontrolled proliferation, survival and immune dysregulation. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting clinical trials with TTI-109 in healthy volunteers and TTI-101 in hepatocellular carcinoma (NCT05440708). To learn more, please visit tvarditherapeutics.com or follow us on LinkedIn and X (Twitter).

Contacts:

For Tvardi:
Tvardi Investor Relations
ir@tvardi.com

PJ Kelleher
LifeSci Advisors
617-430-7579
pkelleher@lifesciadvisors.com

FAQ

When will Tvardi Therapeutics (NASDAQ: TVRD) present at the Jefferies Global Healthcare Conference 2026?

Tvardi Therapeutics will present at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, at 8:10 AM ET. According to Tvardi, the session will feature a fireside chat and 1-on-1 meetings in New York, with a webcast available online.

What is the format of Tvardi Therapeutics’ appearance at the Jefferies healthcare conference 2026?

Tvardi Therapeutics’ management will participate in a fireside chat and 1-on-1 investor meetings at Jefferies. According to Tvardi, the event occurs June 4, 2026, at 8:10 AM ET in New York, with the fireside chat webcast accessible via the company’s investor website.

What are the details of Tvardi Therapeutics’ participation in the Raymond James BioPharma CEO Strategy Series 2026?

Tvardi Therapeutics will join the Raymond James BioPharma CEO Strategy Series on Friday, June 5, 2026, at 10:00 AM ET. According to Tvardi, the appearance will be a fireside chat, with a webcast and registration link available through the company’s investor website.

Where can investors watch the Tvardi Therapeutics (TVRD) investor event webcasts?

Investors can access Tvardi Therapeutics’ Jefferies and Raymond James fireside chat webcasts on the Tvardi investor website. According to Tvardi, replay versions of both webcasts will remain available for approximately 90 days after the respective conferences, supporting ongoing investor review.

How long will replays of Tvardi Therapeutics’ June 2026 investor presentations be available?

Replays of Tvardi Therapeutics’ Jefferies and Raymond James fireside chats will be available for about 90 days. According to Tvardi, these replay webcasts will be hosted on the company’s investor website following each conference, giving shareholders extended time to listen.